Medical device contract research provider Genae (Antwerp, Belgium) recently acquired MedicSense, a clinical, regulatory affairs and quality assurance consultancy firm based in Tel Aviv, Israel. Terms were not disclosed.
“The vast regulatory and quality assurance expertise of the MedicSense team represents a logical expansion of Genae’s value chain of services,” said Genae CEO Bart Segers in a prepared statement. “Being involved in the early stages of the development process lowers the risk of potential re-engineering and accelerates the time to market, while remaining in compliance with worldwide regulatory requirements.”
“Integrating MedicSense in the Genae group addresses the needs of the vibrant, high-tech medical device industry and the dynamic regulatory environment,” added MedicSense co-founders and CEOs Adi Ickowicz and Erez Adiv. “This approach favors the entire service industry and represents a major advantage for the larger multi-disciplinary and more comprehensive service providers.”
MedicSense has been in business for more than 20 years, developing dedicated regulatory strategies, from initial product registration to post-marketing activities. Genae works with companies worldwide on developing devices and therapies. It acquired the digital health data management platform Hilbert Paradox in March 2018.